drugset / Trial / NCT04492813

Plasmatic Concentrations of Propofol and Remifentanil in Obese and Non Obese Patients.

NCT04492813

Non-randomizedParallel-groupSingle-blindBasic science

Summary

This prospective monocentric phamacokinetics study aims to compare plasmatic concentrations of Propofol and Remifentanil required to target a specific range of monitored anesthesia and analgesia during sus-mesocolic surgery in obese and non obese patients.

Timeline

Start
2018-12-20
Primary completion
2021-01-25
Completion
2021-05-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule Intravenous
Subject Remifentanil Small molecule Intravenous

Indications